Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Co-Diagnostics Inc (CODX)

Co-Diagnostics Inc (CODX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,870
  • Shares Outstanding, K 2,095
  • Annual Sales, $ 620 K
  • Annual Income, $ -46,900 K
  • EBIT $ -30 M
  • EBITDA $ -29 M
  • 60-Month Beta 1.42
  • Price/Sales 4.84
  • Price/Cash Flow N/A
  • Price/Book 0.16

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-3.60
  • Number of Estimates 1
  • High Estimate $-3.60
  • Low Estimate $-3.60
  • Prior Year $-7.21
  • Growth Rate Est. (year over year) +50.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3500 +1.48%
on 04/09/26
3.9500 -65.32%
on 03/20/26
-3.0300 (-68.86%)
since 03/10/26
3-Month
1.3500 +1.48%
on 04/09/26
6.1800 -77.83%
on 01/12/26
-4.8200 (-77.87%)
since 01/09/26
52-Week
1.3500 +1.48%
on 04/09/26
46.5000 -97.05%
on 10/27/25
-8.7340 (-86.44%)
since 04/10/25

Most Recent Stories

More News
Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City

Facility in Sudair Industrial City is expected to position CoMira among the early domestic manufacturers of molecular diagnostic testing solutions in Saudi Arabia

CODX : 1.3700 (-4.86%)
Co-Diagnostics Reports Full Year 2025 Financial Results

Advancing Global Commercialization Strategy Through CoSara and CoMira Joint Ventures

CODX : 1.3700 (-4.86%)
Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization

The near-term commencement of clinical studies is expected to align with recent WHO tuberculosis recommendations for near-point-of-care molecular testing and utilizing tongue swab samples

CODX : 1.3700 (-4.86%)
Co-Diagnostics (NASDAQ: CODX) Expands CoSara Distribution Territory Across South Asia

Co-Diagnostics (NASDAQ: CODX) announced that its Indian joint venture, CoSara Diagnostics Pvt. Ltd., has signed an agreement to expand its commercial and distribution territory across South Asia to...

CODX : 1.3700 (-4.86%)
Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia

Expansion into Bangladesh, Pakistan, Nepal, and Sri Lanka increases TAM in region to $13 billion and supports commercialization strategy for the PCR Pro ® and SARAGENE ® product...

CODX : 1.3700 (-4.86%)
Co-Diagnostics to Present at Medical Korea 2026

Co-Dx to join WTC Utah and other Utah legislative and industry delegates March 19-22 in Seoul, South Korea

CODX : 1.3700 (-4.86%)
Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies

SALT LAKE CITY , March 12, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...

CODX : 1.3700 (-4.86%)
Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements

SALT LAKE CITY , March 10, 2026 /PRNewswire/ --  Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...

CODX : 1.3700 (-4.86%)
Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai

SALT LAKE CITY , Feb. 9, 2026 /PRNewswire/ -- Co-Diagnostics, Inc .  (OTC: CODX)  ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...

CODX : 1.3700 (-4.86%)
Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument

CDSCO license on Form MD-5 authorizes CoSara to manufacture PCR Pro instrument in its Ranoli, India facility for sale or distribution

CODX : 1.3700 (-4.86%)

Business Summary

Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology...

See More

Key Turning Points

3rd Resistance Point 1.5833
2nd Resistance Point 1.5367
1st Resistance Point 1.4533
Last Price 1.3700
1st Support Level 1.3233
2nd Support Level 1.2767
3rd Support Level 1.1933

See More

52-Week High 46.5000
Fibonacci 61.8% 29.2527
Fibonacci 50% 23.9250
Fibonacci 38.2% 18.5973
Last Price 1.3700
52-Week Low 1.3500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.